Application for quotation of securities - RAD

Sep 16, 2026 at 8:30 PM EDT · Issued by Radiopharm Theranostics Limited via ASX

Filed with ASX · Sep 16, 2026 at 8:30 PM EDT

On 6ix: 6ix.com/news/application-for-quotation-of-securities-rad-1

Appendix 2A - Application for quotation of securitiesAppendix 2A - Application for quotation of securities1 / 10Announcement SummaryEntity nameRADIOPHARM THERANOSTICS LIMITEDAnnouncement TypeNew announcementDate of this announcementThursday September 17, 2026The +securities to be quoted are:Please...

View Attachment

6ix hasn’t read this filing yet.

Radiopharm Theranostics Limited on 6ix

Earlier from Radiopharm Theranostics

Share purchase plan completedSep 16
Radiopharm Theranostics Selected for Late-Breaking Oral Presentation of Positive Data from Interim Analysis of U.S. Phase 2b Imaging Trial of RAD101 at 2026 Society of Neuro-Oncology Annual MeetingSep 14
RAD oral presentation at SNO26 on RAD101 Phase IIb dataSep 13
Results of MeetingSep 10
Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal AdenocarcinomaSep 9

Later from Radiopharm Theranostics

RADOC New Class Options Range of Units and Top 20 HoldersSep 16
Notification regarding unquoted securities - RADSep 16
Change of Director's Interest Notices x 4Sep 22
Annual Report and Form 20-FSep 30
Appendix 4G and Corporate Governance StatementSep 30

All Radiopharm Theranostics news releases

Follow Radiopharm Theranostics into a list and get an email when it puts out news.

Follow Radiopharm Theranostics